ECONOMIC EVALUATION
You are leaving our website
All applications are handled by the University of Oslo. You’ll be redirected to their website. There is nothing to worry about, if you follow the button below, you are really applying to the right Eu-HEM programme :).
Good luck with your application! Please come back afterwards for more Eu-HEM inspiration.
Help governments and healthcare organizations to spend their budgets wisely
There is an increasing demand for healthcare worldwide. Population ageing, increasing wealth and technological advances, change our needs. Both governments and healthcare organizations need to meet these changing demands within their limited resources. But how do you decide on budgets while you know your decisions immediately affect patients and the health of society as a whole? Medical and policy decision makers need accurate information about the costs and benefits of alternative strategies to address health problems.
So, how can I help?
You will help medical and policy decision makers answering questions like:
- How much should our society be willing to spend on a new pharmaceutical that gives 10% of the patients two or more months to live?
- Should costs, due to absence from work, be included in the cost estimates?
- What is an acceptable threshold for the costs per quality adjusted life year (QALY) for a very expensive orphan drug?
- How can a modelling approach support decisions in health care?
- What is the impact of European pharmaceutical legislation on the accessibility of drugs?
- What are the key concepts of pharmaceutical pricing and market access?
To answer questions about new pharmaceuticals or medical innovations, you need to evaluate the costs and benefits. We will train you to achieve the necessary skills to:
- evaluate costs and benefits in a systematic manner
- to measure quality of life and costs
- develop simulation models that allow estimation of the short- and long-term consequences of interventions as well as the uncertainty in these estimates
With this specialisation you will have the necessary skills to work both in the private and public sector.
Frederick Thielen
Erasmus University Rotterdam
If you have any questions regarding this track, don’t hesitate to reach out to me.
Eline Aas
University of Oslo
If you have any questions regarding this track, don’t hesitate to reach out to me.
SEMESTER 1 — UNIVERSITY OF BOLOGNA
- Fundamentals in Health Economics and Management (I.C.)
- Our Right to Health: Needs, Resources and Society
- Fundamentals of Quantitative Methods in Health and Healthcare (I.C.) or Quantative Methods in Health and Healthcare (I.C.)
- Health Systems or International Law and Health
SEMESTER 2 — ERASMUS UNIVERSITY ROTTERDAM
- Measurement of Patient Preferences using Discrete Choice Experiments
- Pharmaceutical Pricing & Market Access
- Health Care Ethics
- Health Technology Assessment
- Advanced Health Economic Modeling
- Behavioural Decision Theory in Health or Global Health Economics or Health & Economic Development: Policies and Evaluation
SEMESTER 3 — UNIVERSITY OF oslo
- Modeling in Economic Evaluation II
- Research Design
- Topics in Economic Evaluation or Non-Parametric Methods
- Elective
SEMESTER 4 — ONE OF THE UNIVERSITIES IN THE TRACK
- Thesis
“I am all about facts and figures. Making calculations that help top decisionmakers deciding on national health issues, give me the feeling that my job really matters.”
Enjoy the best of Rotterdam and Oslo
This track is a partnership between the Erasmus University Rotterdam (2nd semester) and the University of Oslo (3rd semester). They excel in the fields of health economics, healthcare management and health policy. You will enjoy top academic education in two trendy, multicultural European cities. Both with thriving healthcare sectors and high-quality living standards.
Not convinced yet? Check the other tracks
Economics & Policy
BECOME A FUTURE PROOF HEALTH POLICY ANALYST
Management of Healthcare Institutions
ARE YOU THE NEW LEADER OF A HEALTHCARE INSTITUTION?
Population Health Management
TAKE ON A MANAGEMENT ROLE IN PUBLIC HEALTH
